CD14 and myelodysplastic syndrome: Previously, we have shown that mDia1 is downregulated in the bone marrow of del(5q) and 5q- MDS patients, which is associated with aberrant overexpression of CD14 that contributes to the development of MDS through sensitized innate immune responses [22].